Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DB-1312 by Duality Biologics (Shanghai) for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Squamous Non-Small Cell Lung Cancer....
DB-1312 by Duality Biologics (Shanghai) for Esophageal Cancer: Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Esophageal Cancer. According to GlobalData,...
DB-1312 by Duality Biologics (Shanghai) for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According...
DB-1312 by Duality Biologics (Shanghai) for Solid Tumor: Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Solid Tumor. According to GlobalData,...
DB-1312 by Duality Biologics (Shanghai) for Ovarian Cancer: Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Ovarian Cancer. According to GlobalData,...
DB-1312 by Duality Biologics (Shanghai) for Breast Cancer: Likelihood of Approval
DB-1312 is under clinical development by Duality Biologics (Shanghai) and currently in Phase I for Breast Cancer. According to GlobalData,...